Corona Virus Net is the web resource for anyone interested in Coronaviruses. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (COVID-19) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and humans. Common signs of infection include respiratory symptoms, fever, cough, and shortness of breath. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing. Also avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.
A pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO on 31 December 2019. The outbreak of COVID-19 was declared a Public Health Emergency of International Concern on 30 January 2020 by the WHO. As of March 11th, the WHO declared the rapidly spreading coronavirus outbreak a pandemic, acknowledging that the virus will likely spread to all countries in the world.
The objectives of Corona Virus Net are to be the public and professional information resource for coronaviruses and to serve as a network in the exchange of information and news related to coronaviruses. What do you know about the novel Coronavirus that is causing a health emergency?
- New COVID-19 Hospitalizations Increase | Health News | U.S. News - U.S. News & World Report
Mon, 27 Nov 2023 22:02 GMT
- COVID-19 cases increase in Virginia after holiday travel, experts worry surge on the way - 13newsnow.com WVEC
Wed, 29 Nov 2023 18:01 GMT
- New CDC life expectancy data shows painfully slow rebound from covid - The Washington Post
Wed, 29 Nov 2023 08:05 GMT
- Free COVID tests coming to schools this winter - USA TODAY
Wed, 29 Nov 2023 17:30 GMT
- US life expectancy climbs in 2022 after COVID retreat - Reuters
Wed, 29 Nov 2023 05:48 GMT
- Pfizer takes Poland to court over alleged missed COVID-19 vaccine payments - FiercePharma
Tue, 28 Nov 2023 17:02 GMT
- How Long Does COVID Stay in Your System? - Verywell Health
Wed, 29 Nov 2023 17:04 GMT
- Long covid: What we now know about its causes and possible treatments - New Scientist
Mon, 27 Nov 2023 23:14 GMT
- Japan approves first domestically developed COVID-19 XBB vaccine - The Japan Times
Tue, 28 Nov 2023 06:43 GMT
- OHSU coronavirus (COVID-19) response - OHSU News
Wed, 29 Nov 2023 19:41 GMT
- With coronavirus uptick, should I get a COVID shot? When are new ... - Lookout Santa Cruz
Wed, 29 Nov 2023 19:48 GMT
- Public information film on coronavirus allegedly from the 1970s is a ... - Health Feedback
Tue, 28 Nov 2023 20:28 GMT
- Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate ... - Virology Journal
Tue, 28 Nov 2023 16:48 GMT
- Slovakia moves away from daily coronavirus reports. Is it a problem? - The Slovak Spectator
Mon, 27 Nov 2023 19:10 GMT
- Situation Update #188 - Coronavirus Disease 2019 (COVID-19 ... - ReliefWeb
Sun, 19 Nov 2023 08:00 GMT
- PRO/AH/EDR> COVID-19 update (323): Pfizer vaccine in children, vaccine diplomacy, WHO
Mon, 20 Sep 2021 21:44:10 -0400
COVID-19 -- Worldwide/Unknown
A lower dose of the Pfizer-BioNTech coronavirus vaccine -- one-3rd the amount given to adults and teens -- is safe and triggered a robust immune response in children as young as 5 years old, the drug companies announced in a news release Monday morning.
The finding, eagerly anticipated by many parents and pediatricians, is a crucial step toward the 2-shot coronavirus vaccine regimen becoming available for younger school-aged children, perhaps close to Halloween.
The companies still must
- Consequences of a pandemic for people living with rare diseases and recommendations for maintaining healthcare and participation Wed, 29 Nov 2023 06:00:00 -0500
BACKGROUND: Rare diseases are often characterized by complex symptoms and usually require coordination of multiprofessional treatment during the diagnostic and healthcare processes. In the wake of the COVID-19 pandemic, the healthcare situation and daily life of people with rare diseases and the caregivers of children with rare diseases changed drastically. The aim of the research project RESILIENT-SE-PAN was to assess the situation of people with rare diseases and caregivers during COVID-19 and...
- Structural brain heterogeneity underlying symptomatic and asymptomatic genetic dystonia: a multimodal MRI study Wed, 29 Nov 2023 06:00:00 -0500
CONCLUSIONS: DYT genes phenotypic expression is associated with alterations of both motor and extra-motor WM and GM regions. Asymptomatic genetic status is characterized by a very subtle affection of the WM motor pathway, together with an increased cortical thickness of higher-order frontal regions that might interfere with phenotypic presentation and disease manifestation.
- Importance of Dipole Orientation in Electrostatic Aerosol Filtration Wed, 29 Nov 2023 06:00:00 -0500
Electrostatic charge is a major part of modern-day aerosol filtration media (e.g., N95 respirators and surgical facemasks) that has remained poorly understood due to its complicated physics. As such, charging a fibrous material has relied on empiricism in dire need of a mathematical foundation to further advance product design and optimization. In this concern, we have conducted a series of numerical simulations to improve our understanding of how an electrostatically charged fiber captures...
- Potential Targets and Mechanisms of Bitter Almond-Licorice for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking Wed, 29 Nov 2023 06:00:00 -0500
CONCLUSION: The bitter almond-licorice could be used to treat COVID-19 by inhibiting inflammatory responses and regulating cellular stress. This work is based on data mining and molecular docking, and the findings need to be interpreted with caution..
- Early combination therapy of COVID-19 in high-risk patients Tue, 28 Nov 2023 06:00:00 -0500
CONCLUSION: Early combination treatment of COVID-19 effectively prevented prolonged viral shedding in 85.6% of cases. Considering the rapid viral clearance rates and low toxicity, individualized dual therapy approaches may be beneficial in high-risk patients.
- Higher order neurocognition in pediatric brain tumor survivors: What can we learn from white matter microstructure? Tue, 28 Nov 2023 06:00:00 -0500
CONCLUSIONS: PBTS demonstrate poorer neurocognitive functioning that is linked to differences in WM microstructure, as evidenced by higher diffusivity in the ACR, SLF, and IFOF. These findings support the use of MD in understanding alterations in WM microstructure in PTBS and shed light on potential functions of these pathways.
- Lung ultrasound evaluation in people with cystic fibrosis: A new approach in the pulmonology outpatient clinic Tue, 28 Nov 2023 06:00:00 -0500
CONCLUSIONS: Our study describes LUS findings in pwCF. It also showed a correlation between LUS score and the patients' lung function measured by spirometric indices. We conclude that LUS may be useful in routine monitoring of pwCF in combination with clinical and spirometric assessment.
- A Genome Sequence for the Threatened Whitebark Pine Tue, 28 Nov 2023 06:00:00 -0500
Whitebark pine (WBP, Pinus albicaulis ) is a white pine of subalpine regions in western contiguous US and Canada. WBP has become critically threatened throughout a significant part of its natural range due to mortality from the introduced fungal pathogen white pine blister rust (WPBR, Cronartium ribicola ) and additional threats from mountain pine beetle ( Dendroctonus ponderosae ), wildfire, and maladaptation due to changing climate. Vast acreages of WBP have suffered nearly complete mortality....
- Atrial fibrosis heterogeneity is a risk for atrial fibrillation in pigs with ischaemic heart failure Tue, 28 Nov 2023 06:00:00 -0500
CONCLUSION: Our results suggest that left atrial cross-regional fibrosis difference rather than overall fibrosis level is associated with IHF-related AF susceptibility, presumably by establishing local conduction disturbances and heterogeneity.
- Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study Mon, 27 Nov 2023 06:00:00 -0500
Understanding the development of humoral immune responses of children and adolescents to SARS-CoV-2 is essential for designing effective public health measures. Here we examine the changes of humoral immune response in school-aged children and adolescents during the COVID-19 pandemic (June 2020 to July 2022), with a specific interest in the Omicron variant (beginning of 2022). In our study "Ciao Corona", we assess in each of the five testing rounds between 1874 and 2500 children and adolescents...